KRS: A 30 Year Overnight Success Story

There was a big sort of special session around care us this year. There's some next generation players coming out with compounds that can target both the active and the inactive form of KRS. So that's an interesting mechanism that will be probed out by some of these pre clinical and an earlier stage compounds coming up. All right, now another analysis we like to do here by a century every year is to drill down into a C R's first in human abstracts person human studies being one lens into translational trends at the conference. 25 abstracts at the meeting this week that describe initial data from first and human studies or describe ongoing first and human Studies from which data have yet to be